Searched for
BIOTECH ACQUISITIONS
GSK in talks to buy cancer biotech Nuvalent for more than $9 billionBritish drug giant GSK is reportedly in talks to acquire cancer drugmaker Nuvalent. The deal could be worth over nine billion dollars. Disc...- Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...
- Shastra VC launches $100 million fund to back deeptech, AI startupsThe Bengaluru-based firm said the new vehicle will invest between $500,000 and $3 million in IP-led firms across these sectors. The launch ...
- Want to jump into the 'China is back' rally? Tread carefullyInvestors are increasingly betting that “China is back” as the economy rebounds from years of deflation, helped by strong manufacturing, ex...
- US CEOs seek China business gains from Trump-Xi summitAmerican business leaders are heading to China for a summit with President Xi Jinping. They aim to resolve ongoing business challenges and ...
- The alchemist of Bengaluru: Kiran Mazumdar-Shaw began from a garageKiran Mazumdar-Shaw has named her niece Claire Mazumdar as successor, setting up a gradual leadership transition at Biocon. A pioneer who b...
- Nandini Piramal warns prolonged West Asia war may raise input costsGeopolitical tensions in West Asia are manageable now. However, a prolonged US-Israel war against Iran could raise costs for petrochemical-...
- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
- Sun Pharma looks to outshine rival bids with $13 billion Organon offerSun Pharmaceutical is making its biggest move yet with a $13 billion offer for Organon & Co. This ambitious bid aims to transform the India...
- US Stocks | Kailera soars over 60% in Nasdaq debut as weight-loss drug race heats upKailera Therapeutics shares surged 62.5% in their Nasdaq debut after raising $625 million in a U.S. IPO priced at the top end of its range....
- Capital with purpose: How capital markets are shaping the future of medicine with Dheeraj ChinthalapellyDheeraj Chinthalapelly, with a decade and a half of experience in global capital markets, shares his journey navigating the biotech investm...
- Gilead to buy Germany's Tubulis for up to $5 billion to boost cancer pipelineGilead is making headlines with its planned acquisition of Tubulis GmbH, a Germany-based company, for a maximum of five billion dollars. Th...
- Why US stock market crashes today? Dow, S&P 500 and Nasdaq in deep red – Iran tensions rise and surging oil prices shake Wall StreetWhy US stock market crashes today? Dow Jones, S&P 500 and Nasdaq in deep red today. Wall Street turns sharply lower as US stock market cras...
- Anthropic acquires Coefficient Bio for nearly $400 million: ReportAnthropic acquires startup Coefficient Bio for about $400 million: report
- Rossari Biotech to acquire Unitop Chemicals for Rs 400 croreRossari will initially acquire 65 per cent equity stake in Unitop Chemicals, while the remainder 35 per cent stake will be bought over the ...
- Advanced Enzyme picks up 70% stake in JC BiotechJC Biotech currently commands a 50%+ share in the Indian market, thereby taking Advanced Enzymes’ combined market share to 80%+ post acquis...
- Cipla to invest about Rs 300 cr to acquire stakes in 2 cosDrug maker Cipla on Tuesday said it will invest USD 65 million (nearly Rs 300 crore) over the next three years with a Chinese joint venture...
- Cadila acquires Italian vaccine research company Etna BiotechLeading Indian healthcare major Zydus Cadila said in a regulatory statement here Tusday that it has acquired Italy-based Etna Biotech, a wh...
- Global meltdown raises joint venture opportunities in biotechThe global meltdown may lead to more joint ventures and acquisitions among the foreign and domestic biotech companies in the current fiscal...
- Ranbaxy scouts for biotech acquisitionIndia’s largest drug maker by size, Ranbaxy, is scouting for a biotech acquisition that will give it a strong presence in the global biopha...
Load More
